3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Lymphoid
1
Classical hematology
1
Conditions
Sepsis
1
Neoplasms
1
Febrile Neutropenia
1
Emergencies
1
Interventions
Epoetin Alfa
8
ferric carboxymaltose
6
epoetin beta
6
Meropenem
6
Ceftazidime
5
Vancomycin
4
Darbepoetin alfa
4
apixaban
3
Enoxaparin
3
Ciprofloxacin
3
Cefepime
3
iron isomaltoside 1000
2
ferrous sulfate
2
ferrous fumarate
2
Teicoplanin
2
Radiotherapy
2
Levofloxacin
2
Filgrastim
2
Dalteparin
2
Cholecalciferol
2
Aspirin
2
Amikacin
2
sotorasib
1
posaconazole
1
ferrous succinate
1
ferric gluconate
1
eltrombopag
1
ceftolozane, tazobactam drug combination
1
Vitamin B 12
1
Vaccination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Amoxicillin-Potassium Clavulanate Combination
×
Classical hematology
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled